Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of the Oral γ-Secretase Inhibitor BMS-708163 (Avagacestat): Tolerability Profile, Pharmacokinetic Parameters, and Pharmacodynamic Markers
Tong, Gary, MD, PhD, Wang, Jun-Sheng, PhD, Sverdlov, Oleksandr, PhD, Huang, Shu-Pang, PhD, Slemmon, Randy, PhD, Croop, Robert, MD, Castaneda, Lorna, MS, Gu, Huidong, MS, Wong, Oi, BS, Li, Hewei, MD, PhD, Berman, Robert M., MD, Smith, Christina, DPhil, Albright, Charles F., PhD, Dockens, Randy C., PhD
Published in Clinical therapeutics (01.03.2012)
Published in Clinical therapeutics (01.03.2012)
Get full text
Journal Article